Firebrand rep unloads on socialist prime minister as ‘hordes of military aged men’ swarm European country
NEWYou can now listen to Fox News articles! As shocking videos circulate of migrants pouring over the collapsed border of
Jemele Hill takes aim at Sophie Cunningham as Storm controversy grows over girls supporting women’s sports
Disgraced former ESPN commentator Jemele Hill’s response to the Sophie Cunningham controversy says more about today’s sports media than it
Soccer Wants to Capitalize on the American World Cup—and It’s Already a Disaster
Backlash intensifies on FIFA’s plan to sell part of its World Cup product to private investors. Source link
Soccer Wants to Capitalize on the American World Cup—and It’s Already a Disaster
Backlash intensifies on FIFA’s plan to sell part of its World Cup product to private investors. Source link
Canada GDP Grows in May Amid Expansion in Oil and Gas Activity
Canada’s economy has roared back to life, tracking the strongest growth in roughly three years with an expansion in oil
Passenger on British Airways mayday flight describes fear and shout of ‘I don’t want to die’
A passenger on a British Airways flight that issued a distress call on approach to Heathrow Airport earlier this month
KARR Bluetooth flaw exposes 2.2M cars to theft risk
NEWYou can now listen to Fox News articles! Could a small device hidden beneath your dashboard make your car easier
Two Fed policymakers said stubborn inflation drove their dissenting votes for higher interest rates this week, a sign of mounting internal pressure on Chairman Kevin Warsh to act
The central bankers, Beth Hammack and Neel Kashkari, said Kevin Warsh’s Fed should have raised rates this week in the
Millions of Americans are going without health insurance after the end of Affordable Care Act subsidies. The loss is starting to bleed into the wider healthcare economy.
Millions of Americans dropped their Affordable Care Act plans when subsidies expired and now struggle to pay. Source link
Novo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular Trial
The stock was down 9.5% after the company’s experimental medicine ziltivekimab didn’t achieve the expected risk reduction for major cardiovascular